What is the intrinsic value of SEEL?

As of 2025-07-17, the Intrinsic Value of Seelos Therapeutics Inc (SEEL) is 261.82 USD. This SEEL valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.28 USD, the upside of Seelos Therapeutics Inc is 20,355.00%.

Is SEEL undervalued or overvalued?

Based on its market price of 1.28 USD and our intrinsic valuation, Seelos Therapeutics Inc (SEEL) is undervalued by 20,355.00%.

	Range	Selected	Upside
a
DCF (Growth 5y)	(5,490,931,142.33) - (977,975,431.63)	(1,649,433,600.00)	-128862000100.0%
DCF (Growth 10y)	(363,982,242,468,200.00) - (2,055,882,255,965,888.50)	(615,724,800,000,000.00)	-4.81035000000001e+16%
DCF (EBITDA 5y)	(185,157,448.70) - (275,799,877.98)	(1,234.50)	-123450.0%
DCF (EBITDA 10y)	(68,958,996,367,512.52) - (103,329,949,211,132.92)	(1,234.50)	-123450.0%
Fair Value	261.82 - 261.82	261.82	20,355.00%
P/E	942.57 - 1,181.35	1,005.40	78447.2%
EV/EBITDA	841.96 - 1,911.55	1,368.45	106810.4%
EPV	(15,441.06) - (16,020.41)	(15,730.69)	-1229060.0%
DDM - Stable	165.92 - 1,717.48	941.70	73470.3%
DDM - Multi	(36,847,070.85) - (408,479,645.02)	(76,716,672.00)	-5993490100.0%